ImmunAdd at a Glance
Founded in 2021, ImmunAdd, Inc., is a privately held biopharmaceutical company on a mission to improve health through advances in adjuvant design and formulation.
Founded in 2021, ImmunAdd, Inc., is a privately held biopharmaceutical company on a mission to improve health through advances in adjuvant design and formulation.
ImmunAdd aims to develop next generation adjuvants which are designed to provide better immune-activities in combining with various vaccines and to have better tolerability.
We are seeking partners with whom we can co-develop our adjuvants and vaccines